Nvidia exited its positions in several AI stocks in Q4, but maintained its stake in Recursion Pharmaceuticals. Many investors seemed to view this as a vote of confidence from Nvidia for Recursion.

A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, in New York City, U.S., December 5, 2023. REUTERS/Brendan McDermid/File Photo Johnson ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

Powerful mix of both trader and investor packs with timely expert advice. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery. Early adopters are seeing ...

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...

Lawyers seek $754 million in new Blue Cross antitrust settlement February ... Trump's administration following criticism from the pharmaceutical industry for the Biden-era law.

Shares of Senco Gold, Orchid Pharma, Tarc, Siyaram Silk Mills, ITI, 63 Moons Technologies, Zaggle Prepaid Ocean Services, Concord Biotech, Jai Corp, Blue Jet Healthcare and Indo Tech Transformers were ...

Companies that have grown profits and net profit margins over the past 12 months ...

After hours: February 19 at 5:09:33 PM EST Loading Chart for ACAD ...